A multicenter, dose-finding, phase 1b study of imatinib in combination with alpelisib as third-line treatment in patients with advanced gastrointestinal stromal tumor
一项多中心、剂量探索性、1b期研究,旨在评估伊马替尼联合阿培利西布作为晚期胃肠道间质瘤患者三线治疗的疗效。
期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-022-09610-4
Pantaleo, Maria A; Heinrich, Michael C; Italiano, Antoine; Valverde, Claudia; Schöffski, Patrick; Grignani, Giovanni; Reyners, Anna K L; Bauer, Sebastian; Reichardt, Peter; Stark, Daniel; Berhanu, Ghimja; Brandt, Ulrike; Stefanelli, Tommaso; Gelderblom, Hans